Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

SAGE launches further two Therapeutic Advances journals

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

GE HealthCare Secures CE Mark for...

GE HealthCare has secured CE Mark certification for its...

Revvity Launches GSP T1D 3plex Kit...

Revvity has launched the GSP T1D 3plex kit, a...

The Cigna Group Partners with OpenAI...

The Cigna Group has entered into a strategic partnership...

SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles:Therapeutic Advances in Chronic Diseaseand Therapeutic Advances in Endocrinology and Metabolism.

Therapeutic Advances in Chronic Diseasecovers the drug treatment of all major chronic diseases excluding cancer , publishing guidance on which drugs to use and when (i.e. expert opinion reviews, narrative reviews, analysis of published guidelines (editorials or reviews). Single-drug reviews (including brief reviews of new drugs) and drug class reviews are also published with the aim of providing practically relevant information to the doctor group that treats such patients. Editor-in-Chief of the journal, Michael Schachter, is Senior Lecturer of the National Heart and Lung Institute at Imperial College, London.

Therapeutic Advances in Endocrinology and Metabolic Disorders publishes the highest quality peer-reviewed original research, reviews, and scholarly comment on pioneering efforts and innovative studies in Endocrinology and Metabolism. Aimed at clinicians and researchers from the field it will be a forum for all views and reviews relating to this diverse discipline. The Editor in Chief is Glenn Matfin, specialist in Adult Diabetes and Endocrinology at the Joslin Diabetes Center, USA; the world’s preeminent diabetesresearch and clinical care organization.

Both international in scope, the journals follow the highly successful format of the existing seven Therapeutic Advances titles, offering rapid peer review and publication, with manuscripts published online within seven weeks of acceptance. Each journal publishes six issues per year and will be freely available on the award-winning SAGE Journals Online platform for the first three years of publication.

"The Therapeutic Advances series is a comprehensive and essential addition to medical publishing," said Tessa Picknett, Associate Director and Publisher, STM journals. "Our primary focus is to rapidly publish clinically-relevant, peer-reviewed original research and reviews, written by highly respected authors for busy specialists and other health professionals."

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป